NCT05908266: REACH-PD

Flexible Reaching Control in Parkinson Disease

Recruiting now Last updated 18 June 2023

What this trial tests

trial testing Reaching movements in Parkinson Disease in 100 participants. Currently enrolling.

Timeline

1 May 2023

Primary endpoint
31 October 2027

31 October 2027

Quick facts

Lead sponsor	Université Catholique de Louvain
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 May 2023
Primary completion	31 October 2027
Estimated completion	31 October 2027
Sites	1 location across Belgium

Drugs / interventions tested

• Reaching movements
• Disease Assessment

Conditions studied

• Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

Université Catholique de Louvain — full company profile →

Who can join

Adults 18 to 99, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Current research and theories have highlighted that the parameters linked to movement planning, e.g. the decision to select a movement goal, and adaptation, e.g. the ability to update control dependent on a novel dynamical context, are update quickly and within an ongoing movement in the general population. In parallel, it has been suggested that the evaluation of movement costs is a function of the basal ganglia, and it is impaired in Parkinson disease (PD). Here the investigators want to test whether these mechanisms also alter the ability of patients to update control during an ongoing action. A positive result would confirm that movement-related costs and dynamical representations depend on the integrity of the basal ganglia, in contrast a negative result would indicate that the deficit in PD is more specifically related to movement initiation, which would invite one to reconsider the cause of bradykinesia in this population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.